Comparison Chart Ascendis Pharma A/S

Equities

Real-time Estimate Cboe BZX Other stock markets 12:30:14 2024-09-11 pm EDT			5-day change	1st Jan Change
113.10 ^USD	-1.44%		-5.40%	-10.24%

Sep. 05	Oppenheimer Upgrades Ascendis Pharma A/S to Outperform From Perform, $180 Price Target	MT
Sep. 04	European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ASCENDIS PHARMA A/S	Bio Therapeutic Drugs	-1.49%	-5.40%	-10.24%	+12.98%	+7.37%	6.58B